Polarized Light Therapy for Radiation Dermatitis in Breast Cancer
Recruiting
N/A
Interventional Study
Radio Dermatitis
Polarized Light
Breast Cancer Survivors
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 35 – 55
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Beni-Suef University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This assessor-blinded randomized controlled trial aims to evaluate the efficacy of polarized polychromatic non-coherent light therapy as an adjunct to standard skin care in reducing acute radiation dermatitis in women with breast cancer undergoing hypofractionated whole-breast radiotherapy. Participants will be randomly allocated to receive either standard skin care alone or standard care combined…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Female patients aged 35-55 years.
2. Histologically confirmed primary unilateral breast cancer.
3. Status post breast-conserving surgery (lumpectomy).
4. Planned for hypo fractionated whole-breast irradiation (HFWBI).
5. Scheduled to receive a total radiation dose of 40-42.5 …
Contacts